chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test
Clinical narrative: Positive pregnancy test; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Positive pregnancy test) in a 33-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Hyperemesis in December 2020. Concomitant products included ONDANSETRON (ZOFRAN [ONDANSETRON]) for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 25-Aug-2021. On 17-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Positive pregnancy test). At the time of the report, EXPOSURE DURING PREGNANCY (Positive pregnancy test) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Dec-2021, Pregnancy test: positive (Inconclusive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site urticaria
Clinical narrative: Reddish purple; Big red welt in the injection site, seems to be getting bigger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Reddish purple) and VACCINATION SITE URTICARIA (Big red welt in the injection site, seems to be getting bigger) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.   Concurrent medical conditions included Thyroid disorder, Hypertension, Diabetes mellitus and Dyslipidemia. Concomitant products included RITUXIMAB (RITUXAN) for an unknown indication.  On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Reddish purple) and VACCINATION SITE URTICARIA (Big red welt in the injection site, seems to be getting bigger). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; Physical therapy (Ice therapy) for Vaccination site discolouration and Physical therapy (Ice therapy) for Vaccination site urticaria. At the time of the report, VACCINATION SITE DISCOLOURATION (Reddish purple) and VACCINATION SITE URTICARIA (Big red welt in the injection site, seems to be getting bigger) outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  The concomitant medications included thyroid medicine, high blood pressure medicine, Diabetes medicines, and cholesterol medications.
Age: 65.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: Diarrhea; Dizziness; Joint aches; Serious fatigue; Generally headache; Low grade fever (highest I've had is 100); GI symptoms largely nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), HEADACHE (Generally headache), PYREXIA (Low grade fever (highest I've had is 100)) and NAUSEA (GI symptoms largely nausea) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced HEADACHE (Generally headache), PYREXIA (Low grade fever (highest I've had is 100)) and NAUSEA (GI symptoms largely nausea). On 18-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), ARTHRALGIA (Joint aches) and FATIGUE (Serious fatigue). At the time of the report, DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), HEADACHE (Generally headache), PYREXIA (Low grade fever (highest I've had is 100)), NAUSEA (GI symptoms largely nausea), ARTHRALGIA (Joint aches) and FATIGUE (Serious fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Pyrexia: 100 (High) 100.
Age: 65.0
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Diarrhea; Dizziness; Joint aches; Serious fatigue; Generally headache; Low grade fever (highest I've had is 100); GI symptoms largely nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), HEADACHE (Generally headache), PYREXIA (Low grade fever (highest I've had is 100)) and NAUSEA (GI symptoms largely nausea) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced HEADACHE (Generally headache), PYREXIA (Low grade fever (highest I've had is 100)) and NAUSEA (GI symptoms largely nausea). On 18-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), ARTHRALGIA (Joint aches) and FATIGUE (Serious fatigue). At the time of the report, DIARRHOEA (Diarrhea), DIZZINESS (Dizziness), HEADACHE (Generally headache), PYREXIA (Low grade fever (highest I've had is 100)), NAUSEA (GI symptoms largely nausea), ARTHRALGIA (Joint aches) and FATIGUE (Serious fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Pyrexia: 100 (High) 100.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site warmth
Clinical narrative: Hot red rash at the injection site; Hot red rash at the injection site; Hot red rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot red rash at the injection site), VACCINATION SITE ERYTHEMA (Hot red rash at the injection site) and VACCINATION SITE RASH (Hot red rash at the injection site) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included ALLOPURINOL and NAPROXEN for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot red rash at the injection site), VACCINATION SITE ERYTHEMA (Hot red rash at the injection site) and VACCINATION SITE RASH (Hot red rash at the injection site). At the time of the report, VACCINATION SITE WARMTH (Hot red rash at the injection site), VACCINATION SITE ERYTHEMA (Hot red rash at the injection site) and VACCINATION SITE RASH (Hot red rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Eye pain, Headache, Heart rate, Hypertension
Clinical narrative: soreness on her arm; visual problems; moderate pain behind her left eye and forehead; High blood pressure; moderate pain behind her left eye and forehead; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (soreness on her arm), VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead), HYPERTENSION (High blood pressure) and HEADACHE (moderate pain behind her left eye and forehead) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040a21a) for COVID-19 vaccination.     Concomitant products included THYROID, HYDROCODONE, APIXABAN (ELIQUIS), METOPROLOL and LORAZEPAM (ATIVAN) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead), HYPERTENSION (High blood pressure) and HEADACHE (moderate pain behind her left eye and forehead). On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness on her arm). At the time of the report, PAIN IN EXTREMITY (soreness on her arm), VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead) and HEADACHE (moderate pain behind her left eye and forehead) had resolved and HYPERTENSION (High blood pressure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: abnormal (High) 132-77, 140-82 and 152. On an unknown date, Heart rate: 57 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Visual impairment
Clinical narrative: soreness on her arm; visual problems; moderate pain behind her left eye and forehead; High blood pressure; moderate pain behind her left eye and forehead; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (soreness on her arm), VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead), HYPERTENSION (High blood pressure) and HEADACHE (moderate pain behind her left eye and forehead) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040a21a) for COVID-19 vaccination.     Concomitant products included THYROID, HYDROCODONE, APIXABAN (ELIQUIS), METOPROLOL and LORAZEPAM (ATIVAN) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead), HYPERTENSION (High blood pressure) and HEADACHE (moderate pain behind her left eye and forehead). On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness on her arm). At the time of the report, PAIN IN EXTREMITY (soreness on her arm), VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead) and HEADACHE (moderate pain behind her left eye and forehead) had resolved and HYPERTENSION (High blood pressure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: abnormal (High) 132-77, 140-82 and 152. On an unknown date, Heart rate: 57 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: I'm feeling bad after receiving the second dose of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I'm feeling bad after receiving the second dose of the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (I'm feeling bad after receiving the second dose of the Moderna vaccine). At the time of the report, FEELING ABNORMAL (I'm feeling bad after receiving the second dose of the Moderna vaccine) outcome was unknown. Not Provided          concomitant medications are not provided. Treatment information does not provided. The action taken with the drug was Not applicable.   Reporter did not allow further contact
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Passed the 37 day mark for second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Passed the 37 day mark for second dose) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Passed the 37 day mark for second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Passed the 37 day mark for second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment details was not provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Received the 1st dose, and Have not received the 2nd dose of the Moderna vaccine yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received the 1st dose, and Have not received the 2nd dose of the Moderna vaccine yet) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Hypertension and Cholesterol.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received the 1st dose, and Have not received the 2nd dose of the Moderna vaccine yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received the 1st dose, and Have not received the 2nd dose of the Moderna vaccine yet) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include Diabetic medication, blood pressure medication, Cholesterol medication. No treatment medication details was reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), PYREXIA (102 F degree fever) and FATIGUE (feel tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm), PYREXIA (102 F degree fever) and FATIGUE (feel tired). At the time of the report, VACCINATION SITE PAIN (sore arm), PYREXIA (102 F degree fever) and FATIGUE (feel tired) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) high units: degrees F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Peripheral swelling, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: started itching again; noticed raised, red area about the size of her hand on her arm; sore, hot, itchy arm; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (sore, hot, itchy arm), FATIGUE (Tired), VACCINATION SITE PRURITUS (started itching again) and VACCINATION SITE ERYTHEMA (noticed raised, red area about the size of her hand on her arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concomitant products included ETANERCEPT (ENBREL) for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (sore, hot, itchy arm) and FATIGUE (Tired). On 17-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (started itching again) and VACCINATION SITE ERYTHEMA (noticed raised, red area about the size of her hand on her arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (sore, hot, itchy arm), FATIGUE (Tired), VACCINATION SITE PRURITUS (started itching again) and VACCINATION SITE ERYTHEMA (noticed raised, red area about the size of her hand on her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included cool towel
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 18-Mar-2021, the patient experienced CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 10-Mar-2021, PAIN IN EXTREMITY (arm pain) outcome was unknown. At the time of the report, CHILLS (chills), FATIGUE (tired) and NAUSEA (nauseous) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Both hands are itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Both hands are itching) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PRURITUS (Both hands are itching). At the time of the report, PRURITUS (Both hands are itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Lymphocyte count
Clinical narrative: Sweats; Sleeping for 10-12 hours; throat closing off on the right side; Headache; Extreme fatigue; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERHIDROSIS (Sweats), SOMNOLENCE (Sleeping for 10-12 hours), THROAT TIGHTNESS (throat closing off on the right side), HEADACHE (Headache) and FATIGUE (Extreme fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Epstein Barr virus positive mucocutaneous ulcer.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweats), SOMNOLENCE (Sleeping for 10-12 hours), THROAT TIGHTNESS (throat closing off on the right side), HEADACHE (Headache), FATIGUE (Extreme fatigue) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweats), HEADACHE (Headache) and CHILLS (Chills) had resolved and SOMNOLENCE (Sleeping for 10-12 hours), THROAT TIGHTNESS (throat closing off on the right side) and FATIGUE (Extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Lymphocyte count: high (High) high. On 12-Mar-2021, Neutrophil count: low (Low) low.         Bloodwork was done which showed high lymphocytes and a low neutrophil count.  Treatment with a heating pad was reported.
Sex: F
Vaccine: COVID19
Symptoms: Neutrophil count, Somnolence, Throat tightness
Clinical narrative: Sweats; Sleeping for 10-12 hours; throat closing off on the right side; Headache; Extreme fatigue; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERHIDROSIS (Sweats), SOMNOLENCE (Sleeping for 10-12 hours), THROAT TIGHTNESS (throat closing off on the right side), HEADACHE (Headache) and FATIGUE (Extreme fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Epstein Barr virus positive mucocutaneous ulcer.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweats), SOMNOLENCE (Sleeping for 10-12 hours), THROAT TIGHTNESS (throat closing off on the right side), HEADACHE (Headache), FATIGUE (Extreme fatigue) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweats), HEADACHE (Headache) and CHILLS (Chills) had resolved and SOMNOLENCE (Sleeping for 10-12 hours), THROAT TIGHTNESS (throat closing off on the right side) and FATIGUE (Extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Lymphocyte count: high (High) high. On 12-Mar-2021, Neutrophil count: low (Low) low.         Bloodwork was done which showed high lymphocytes and a low neutrophil count.  Treatment with a heating pad was reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Condition aggravated, Confusional state, Fatigue, Pain in extremity
Clinical narrative: Confusion; Balance was off; Aggravation; Sore arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), BALANCE DISORDER (Balance was off), CONDITION AGGRAVATED (Aggravation), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M2A) for COVID-19 vaccination.     Concomitant products included METOPROLOL TARTRATE, SERTRALINE, NAPROXEN, ALPRAZOLAM (XANAX) and AMITRIPTYLINE for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced CONFUSIONAL STATE (Confusion), BALANCE DISORDER (Balance was off), CONDITION AGGRAVATED (Aggravation), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue). At the time of the report, CONFUSIONAL STATE (Confusion), BALANCE DISORDER (Balance was off), CONDITION AGGRAVATED (Aggravation), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not provided,
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided. Concomitant medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received dose after the 6hrs punctured vial; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose after the 6hrs punctured vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021 at 6:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose after the 6hrs punctured vial). On 10-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Received dose after the 6hrs punctured vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vial was opened at 9am and the dose was given at 6pm. No relevant concomitant medications were reported. No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Pain and swelling in arm; Pain and swelling in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain and swelling in arm) and PERIPHERAL SWELLING (Pain and swelling in arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain and swelling in arm) and PERIPHERAL SWELLING (Pain and swelling in arm). At the time of the report, PAIN IN EXTREMITY (Pain and swelling in arm) and PERIPHERAL SWELLING (Pain and swelling in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported by the reporter No treatment medications was  provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Dizziness, Feeling hot, Headache
Clinical narrative: Dizzy; Shakes; Lower back pain; Runny nose; Arm on fire; Sore; Rash on chest; Fever 103; Bad headache; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose) and FEELING HOT (Arm on fire) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose), FEELING HOT (Arm on fire), PAIN (Sore), RASH (Rash on chest), PYREXIA (Fever 103), HEADACHE (Bad headache) and NAUSEA (Nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose), FEELING HOT (Arm on fire), PAIN (Sore), RASH (Rash on chest), PYREXIA (Fever 103), HEADACHE (Bad headache) and NAUSEA (Nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 103 (High) fever of 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Rash, Rhinorrhoea
Clinical narrative: Dizzy; Shakes; Lower back pain; Runny nose; Arm on fire; Sore; Rash on chest; Fever 103; Bad headache; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose) and FEELING HOT (Arm on fire) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose), FEELING HOT (Arm on fire), PAIN (Sore), RASH (Rash on chest), PYREXIA (Fever 103), HEADACHE (Bad headache) and NAUSEA (Nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose), FEELING HOT (Arm on fire), PAIN (Sore), RASH (Rash on chest), PYREXIA (Fever 103), HEADACHE (Bad headache) and NAUSEA (Nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 103 (High) fever of 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Dizzy; Shakes; Lower back pain; Runny nose; Arm on fire; Sore; Rash on chest; Fever 103; Bad headache; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose) and FEELING HOT (Arm on fire) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose), FEELING HOT (Arm on fire), PAIN (Sore), RASH (Rash on chest), PYREXIA (Fever 103), HEADACHE (Bad headache) and NAUSEA (Nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizzy), TREMOR (Shakes), BACK PAIN (Lower back pain), RHINORRHOEA (Runny nose), FEELING HOT (Arm on fire), PAIN (Sore), RASH (Rash on chest), PYREXIA (Fever 103), HEADACHE (Bad headache) and NAUSEA (Nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 103 (High) fever of 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Foggy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Foggy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced FEELING ABNORMAL (Foggy). On 19-Feb-2021, FEELING ABNORMAL (Foggy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No laboratory details were  provided.  No treatment medications were reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Somnolence
Clinical narrative: Pain; drowsy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) and SOMNOLENCE (drowsy) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Heart attack (had several heart attacks ) and Bypass surgery (several heart attacks which required bypass and is on several medications ). Concurrent medical conditions included Cancer (Patient also discloses he is going through cancer treatment).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN (Pain) and SOMNOLENCE (drowsy). At the time of the report, PAIN (Pain) and SOMNOLENCE (drowsy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were reported. The patient reported that he is on several concomitant medications.   This case was linked to MOD-2021-051935 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: SHOULDER PAIN; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (SHOULDER PAIN) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced ARTHRALGIA (SHOULDER PAIN). At the time of the report, ARTHRALGIA (SHOULDER PAIN) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment details were provided.
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Vaccine leaked out; A spontaneous report was received from a physician assistant concerning an unknown age male patient who was going to receive Moderna's COVID-19 vaccine (mRNA-1273) and when the syringe dislodged and fell to the floor, a lot of the vaccine leaked out (Incorrect dose administered).   The patient's medical history was not reported. Relevant concomitant medications were not reported.   On 19 Mar 2021, the patient was going to receive their first of two planned doses of mRNA-1273 (lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 19 Mar 2021, the patient was receiving the vaccine, when the syringe dislodged and fell to the floor, a lot of the vaccine leaked out (small puddle) not able to really estimate how much of the vaccine was lost. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, vaccine leaked out was considered as resolved on 19 Mar 2021.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273 with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Gait inability, Memory impairment, Tremor
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Trembling all over), MEMORY IMPAIRMENT (Foggy memory) and GAIT INABILITY (Unable to walk) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 015M20A) for COVID-19 vaccination.  Concomitant products included IBUPROFEN for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced TREMOR (Trembling all over), MEMORY IMPAIRMENT (Foggy memory) and GAIT INABILITY (Unable to walk). At the time of the report, TREMOR (Trembling all over), MEMORY IMPAIRMENT (Foggy memory) and GAIT INABILITY (Unable to walk) outcome was unknown. Not Provided. No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Insomnia, Neck pain
Clinical narrative: Feels terrible; Did not sleep last night; Neck is killing them; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feels terrible), INSOMNIA (Did not sleep last night) and NECK PAIN (Neck is killing them) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007Z21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced FEELING ABNORMAL (Feels terrible), INSOMNIA (Did not sleep last night) and NECK PAIN (Neck is killing them). At the time of the report, FEELING ABNORMAL (Feels terrible), INSOMNIA (Did not sleep last night) and NECK PAIN (Neck is killing them) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. Concomitant medications was not provided by the reporter. Treatment included antibiotics and stopped.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: erythema; sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA (erythema) and PAIN IN EXTREMITY (sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (erythema) and PAIN IN EXTREMITY (sore arm). At the time of the report, ERYTHEMA (erythema) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Warm to the touch Left Arm Post first vaccine; Red Left Arm Post first vaccine; Itchy Left Arm Post first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch Left Arm Post first vaccine), VACCINATION SITE ERYTHEMA (Red Left Arm Post first vaccine) and VACCINATION SITE PRURITUS (Itchy Left Arm Post first vaccine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 206M20A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch Left Arm Post first vaccine), VACCINATION SITE ERYTHEMA (Red Left Arm Post first vaccine) and VACCINATION SITE PRURITUS (Itchy Left Arm Post first vaccine). On 17-Feb-2021, VACCINATION SITE ERYTHEMA (Red Left Arm Post first vaccine) and VACCINATION SITE PRURITUS (Itchy Left Arm Post first vaccine) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch Left Arm Post first vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included anti-itch cream. Concomitant medication not reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-051936 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051936:2nd dose
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain
Clinical narrative: Left breast has been sore; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Left breast has been sore) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (Left breast has been sore). At the time of the report, BREAST PAIN (Left breast has been sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: nauseous; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (nauseous). At the time of the report, NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided.  No treatment drugs were reported.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling abnormal
Clinical narrative: shortness of breath; felt crappy; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) and FEELING ABNORMAL (felt crappy) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 030M20A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac) (on her left side). Concurrent medical conditions included Penicillin allergy. Concomitant products included ATENOLOL and APIXABAN (ELIQUIS) for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath) and FEELING ABNORMAL (felt crappy). At the time of the report, DYSPNOEA (shortness of breath) and FEELING ABNORMAL (felt crappy) outcome was unknown.            No treatment medications were reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: experienced fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (experienced fever) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (NO MEDICAL HISTORY REPORTED).   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (experienced fever). At the time of the report, PYREXIA (experienced fever) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.